EBITDA: INR 760 crores, with 17.8% YoY growth. EBITDA margin for solar manufacturing business was 29.3%.
PAT: INR 462 crores, with 30.8% YoY growth. PAT margin for solar manufacturing business was 17.9%.
Subsidiary Performance: Transcon reported revenue of INR 122 crores and PAT of INR 18 crores, with EBITDA margin of 15% and PAT margin of 8%.
The moderation in PAT margin was attributed to increased depreciation and reduction in other income.
Business Updates and Operational Highlights
7 GW TOPCon Cell Line: Successfully commissioned with trial runs underway. Commercial production expected to start later in November 2026.
Capacity Utilization: Operational cell plants delivered record capacity utilization during the quarter.
New Order Wins: Secured new orders totaling INR 4,001 crores for cells and modules, increasing total order book to INR 16,260 crores.
Transformer Business: Healthy order intake with total order book at INR 330 crores.
Expansion Initiatives: All expansion projects, including battery energy storage, are on track.
Market Outlook and Sector Commentary
Solar Capacity Addition: Steady growth throughout the year with PM Surya Ghar Yojana compensating for slight weakness in utility scale segment.
Annual Capacity Projection: Expected to reach around 50 GW AC territory, surpassing previous year's numbers.
Long-term Outlook: Compelling sector outlook with government initiatives to reduce fossil fuel dependence and combat climate change.
Policy Impact: Recent announcements on transmission and storage capacity additions expected to unlock next growth cycle.
Commodity Price Impact: Middle East war has caused material increases in raw material prices and delivery timeline delays.
Expansion Projects Timeline
Battery Energy Storage System: Expected operationalization in Q2 FY27 (Q2 of fiscal year 2027).
Localization Efforts: Working to localize container manufacturing and fire suppression systems to achieve 40% localization requirement for subsidy programs.
Ingot-Wafer Plant:
Phase 1 (5 GW): Expected commissioning by December 2027
Phase 2 (additional 5 GW): Expected commissioning by June 2028, taking total capacity to 10 GW
Land procured, permits and licenses in place, water allocation completed, electricity power approval obtained
Partnership Details
BESS Partnership with RCT: German company with CE and UL-certified products in Europe and U.S.
Partnership provides access to European and U.S. markets, EMS solutions, and existing customer base
Technology transfer and market access for Indian-manufactured BESS solutions
Order Book Analysis
Total Order Book: INR 16,260 crores
Business Mix: Approximately 48% each for cell and module business
DCR vs Non-DCR: Within module business, approximately 20% is DCR business
Overall DCR Exposure: Approximately 68-70% of total order book is for domestic manufacturing (DCR) business
Pricing Environment
DCR Module Pricing:
Retail segment: INR 23-24 per watt
KUSUM C & C&I market: INR 21-21.5 per watt
IPP segment: INR 20-20.5 per watt (for deliveries up to March 2027)
Average realization: INR 21.5-22 per watt
Cell Pricing:
Mono PERC: $0.12-0.125
TOPCon: $0.14-0.145
Non-DCR Module Pricing: INR 12.75-13 per watt with price premium due to high-quality BOM and automated manufacturing lines
Inventory Management
Inventory Buildup: Primarily on raw material side, not finished goods
Reasons for Increase:
Ramp-up of Seetharampur and Naidupeta plants requiring advance inventory positioning
War-related delivery timeline impacts and port congestion
Maintenance of extra buffer inventory due to supply chain uncertainties
Normalization Expected: By March 2027 quarter as new plants stabilize and revenue increases
Capital Expenditure
FY27 Capex Guidance: Approximately INR 2,400 crores for the financial year
Q3-Q4 FY27 Capex: Approximately INR 700 crores for next two quarters
Capex Components: Marginal payments for Naidupeta cell plant, battery and aluminum plant, open access captive projects
Capacity Ramp-up Schedule
7 GW Naidupeta Plant:
December 2026: 25-30% capacity utilization factor (CUF)
March 2027: 70% CUF target
Transformer Business:
4 GVA new capacity already commissioned
Type testing completed for full range except EHV segment
Expected gradual ramp-up to 80-90% capacity utilization over three years
Revenue expected to more than treble over three-year period
Technology and Equipment Sourcing
Chinese Export Controls: Draft policy under consultation, final outcome expected in 3-4 weeks
Current Status: High-technology equipment already imported for Naidupeta cell line
Ingot-Wafer Equipment: Orders not yet placed, small deposit with vendor for wafer equipment
Pre-existing Agreements: Equipment agreements being registered with Chinese government for export control considerations
International Expansion Plans
Geographies of Interest: U.S. and Europe markets
U.S. Plans: Advanced stages to finalize factory location with JV partner, cell manufacturing planned
Timeline: 12-18 months for finalization
Strategy: Focus on markets with strong policy push for domestic manufacturing
Margin Guidance
Solar Manufacturing: Margins expected to be maintained subject to cost environment volatility
Transformer Business: Normalized margins expected at 15% (compared to 22% in previous quarter and 12% in current quarter)
Credit Rating: A+ rating reflecting strong financial position
CWIP: INR 2,900 crores as of September 30, primarily for cell line not yet commercialized
Depreciation: Expected to be around INR 600 crores for the full year
Funding: Sufficient cash flow from operations to fund capex plans, no QIP planned in near future
Market Development Outlook
Policy Initiatives: Surya Ghar Yojana 2.0 and KUSUM 2.0 expected to be announced in next 1-2 months
Demand Segments: Retail demand strong, C&I demand expected to pick up with DCR regulation implementation
Industry Structure: Backward integration (ingot-wafer) becoming critical differentiator, scale players with financial bandwidth expected to lead consolidation
Corporate Actions Clarification
Block Deal Rumors: No block deal from promoters planned in next couple of years
GEF Stake: No appointment of Citi as banker, no block deal planned
QIP Plans: Only enabling resolution, no near-term plans due to sufficient operational cash flows